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Abnormalities of tau protein are central to the pathogenesis of progressive supranuclear palsy, whereas
haplotype variation of the tau geneMAPT inﬂuences the risk of Parkinson disease and Parkinson’s disease
dementia. We assessed whether regional MAPT expression might be associated with selective vulnera-
bility of global brain networks to neurodegenerative pathology. Using task-free functional magnetic
resonance imaging in progressive supranuclear palsy, Parkinson disease, and healthy subjects (n ¼ 128),
we examined functional brain networks and measured the connection strength between 471 gray matter
regions. We obtainedMAPT and SNCAmicroarray expression data in healthy subjects from the Allen brain
atlas. Regional connectivity varied according to the normal expression of MAPT. The regional expression
of MAPT correlated with the proportionate loss of regional connectivity in Parkinson’s disease. Executive
cognition was impaired in proportion to the loss of hub connectivity. These effects were not seen with
SNCA, suggesting that alpha-synuclein pathology is not mediated through global network properties. The
results establish a link between regional MAPT expression and selective vulnerability of functional brain
networks to neurodegeneration.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Several neurodegenerative diseases are associated with the
hyperphosphorylation, misfolding, and aggregation of the
microtubule-associated protein tau, including progressive supra-
nuclear palsy (PSP), frontotemporal dementia, and Alzheimer’s
disease. Genetic variations in the tau gene MAPT also increase
the risk of PSP, frontotemporal dementia, Parkinson disease (PD)
(Martin et al., 2001; Satake et al., 2009; Simón-Sánchez et al., 2009),
and dementia in PD (Goris et al., 2007). Each of these disorders iseurosciences, Herchel Smith
y, Cambridge CB2 0SZ, UK.
an).
Inc. This is an open access articleassociated with selective vulnerability of distinct brain regions
within distributed functional brain networks (Zhou et al., 2012).
Although there are suggestions that tau haplotype may contribute
(Winder-Rhodes et al., 2015) to its association with these diseases,
the mechanisms behind this susceptibility remain unclear.
The misfolded and hyperphosphorylated tau protein may pro-
vide a pathogenic template for the propagation and spread of tau
pathology. For example, in transgenic murine models, it has been
shown that tau can propagate via trans-synaptic spread (Ahmed
et al., 2014; Liu et al., 2012), which promotes the transformation
of normally expressed tau to pathogenic species (Clavaguera et al.,
2013). Here, we propose that high levels of the intrinsic expression
of tau in humans may enhance this templating process, thereby
accelerating the pathogenesis of neurodegenerative disordersunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Demographics for all patient groups
Demographic Control PD PSP p-value
Mean age
(range)
66.7 (40.6e84.4) 66.8 (46.9e77.0) 70.8 (58.3e92.5) ns
Handedness
(R/L)
52/1 29/1 40/5 ns
Gender
(M:F)
30/23 15/15 23/22 ns
UPDRS III
(range)
d 20.8 (7e38) 36.7 (8e69) <0.00001
PSPRS d d 38.3 (13e79) d
MMSE (range) 29 (26e30) 28.4 (23e30) 24.5 (7e30) <0.00001
Themean and range are shownwhere appropriate. Statistical comparison wasmade
using analysis of variance for age andMMSE, t test for UPDRS, and chi-square test for
handedness and gender.
Key: F, female; M, male; MMSE, Mini-Mental State Examination; ns, nonsigniﬁcant
p > 0.1; PSPRS, Progressive Supranuclear Palsy Rating Scale, UPDRS, Uniﬁed
Parkinson’s Disease Rating Scale.
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of the abnormal tau species. We predicted that brain regions with a
higher expression of tau in healthy adulthood are more susceptible
to a loss of function in the human diseases. We predict this would
be true in neurodegenerative syndromes associated with tau
pathology such as PSP, as well as other diseases associated with
genetic variation of MAPT such as PD. To test this hypothesis, we
examined the regional expression of MAPT in a cohort of healthy
subjects from the Allen Brain atlas.
We contrasted the effect in MAPT with SNCA, the gene encoding
alpha-synuclein, which is associated with the pathology of PD but
not PSP. Alpha-synuclein neuropathology in PD is localized to
brainstem nuclei and the basal ganglia in early PD (Braak et al.,
2003). In our population of PD subjects without dementia, we
would therefore expect SNCA expression to have a limited effect on
global network measures relevant to cognition.
We used functional brain networks to look for an association
between genetic and clinical descriptions, both in a healthy older
cohort and in neurodegeneration (Hawrylycz et al., 2015; Meyer-
Lindenberg and Weinberger, 2006; Richiardi et al., 2015).
The analysis of the organization of large scale functional brain
networks in health and neuropsychiatric disease exploits the syn-
chronization of activity across neuronal populations in functionally
and anatomically deﬁned networks (Bullmore and Sporns, 2009).
Within these distributed networks, highly connected hub regions
enhance network efﬁciency by connecting topologically remote
regions (Power et al., 2013; Sporns et al., 2007). However, highly
connected “hub” regions may be particularly susceptible to neu-
rodegeneration in Alzheimer’s disease (Buckner et al., 2009) and
other brain disorders (Crossley et al., 2014).
We therefore started by examining the association between
functional connection strength in health and gene expression, then
went on to associate connection strength and gene expression with
the proportional loss of connection strength in PSP. We focused on
hub regions to explore the link between functional connection
strength and cognition in PD and PSP.2. Methods
2.1. Subjects
A total of 146 subjects (60 age-matched controls, 30 PD without
dementia Mini-Mental State Examination >26/30, 56 PSP) were
recruited with written informed consent and approval from the
local ethics committee. Of these, 16 were excluded after functional
magnetic resonance imaging (fMRI) image preprocessing revealed a
focal lesion, signiﬁcant white matter hyperintensities, or motion
dependent confounds on connectivity measures. In the remaining
128 participants (53 controls, 30 PD, 45 PSP), there were no group
differences in age, gender, handedness or years of education; as
expected, cognition was more impaired in PD and PSP groups using
the MMSE (Table 1). For motor function, we report both the Uniﬁed
Parkinson’s Disease Rating Scale, and for motor and nonmotor
symptoms in the PSP group, the PSP Rating Scale (PSPRS) (Golbe
and Ohman-Strickland, 2007). Verbal ﬂuency testing required
subjects to generate words beginning with the letter “p” (letter
ﬂuency) or animals (category ﬂuency), each for 1 minute. These 2
scores were added together to produce a combined verbal ﬂuency
score.
Microarray data from 6 postmortem brain samples were obtained
from the Allen Institute at http://human.brain-map.org (H0351.1009,
H0351.1016, H0351.1015, H0351.2002, H0351.1012, and H0351.2001),
mean age 45.5 (range 24e57), all male, 4 right-handed, 1 left-
handed, and 1 ambidextrous.2.2. Image preprocessing
Imaging was performed at theWolfson Brain Imaging Centre, on
a 3T Tim TRIO Siemens MRI scanner. Medication was not altered
before scanning. Task-free echo-planar fMRI was acquired for a
minimum of 145 volumes with subjects instructed to keep their
eyes open (repetition time [TR] ¼ 2 seconds, echo time [TE] ¼
30ms, ﬂip angle¼ 78, voxel size¼ 3 3 3.75mm) and structural
Magnetization-Prepared Rapid Acquisition with Gradient Echo
scanning in the same session (TR ¼ 2.3 seconds, TE ¼ 2.98, ﬂip
angle ¼ 9, voxel size ¼ 1 mm isotropic).
Preprocessing of structural scans involved optimized skull-
stripping for atrophied brains (Acosta-Cabronero et al., 2008) us-
ing afﬁne transformation followed by nonlinear warping using the
FSL FNIRT tool to a group-speciﬁc template to ameliorate the
challenge of warping atrophied brains before nonlinear trans-
formation to Montreal Neuroscience Institute (MNI) standard
space. Functional image preprocessing was tailored tominimize the
effect of motion, which can inﬂuence the correlation between dis-
tance and connectivity (Patel et al., 2014), and atrophy in neuro-
degenerative disease. The pipeline used a customized version of the
fMRI signal processing toolbox (www.brainwavelet.org) and
included discarding the ﬁrst 5 volumes, slice-timing correction,
coregistration to the Magnetization-Prepared Rapid Acquisition
with Gradient Echo image, motion correction, regression of motion
derivatives, white matter and CSF signal, local median despiking,
high-pass band ﬁltering of 0.01 Hz, and normalization to MNI
standard space using parameters obtained from normalization of
the structural image (performed in the described order). Quality
control included (1) visual inspection at each preprocessing stage;
and (2) measuring the inﬂuence of motion on correlation assessed
using delta-BOLD and framewise displacement correlations, in a
modiﬁed protocol from Power et al. (2011) and Satterthwaite et al.
(2012). More speciﬁcally, subjects were excluded if there was
greater than 5-mm framewise displacement between any 2 TR in-
tervals and if there was a signiﬁcant correlation between motion
and the change in BOLD signal measured by wavelet correlation
before and after a “scrubbing” procedure (delta-BOLD).2.3. Network analysis
A parcellation scheme divided gray matter of the MNI standard
space template in to 500 nonoverlapping regions of equal size,
using centroidal Voronoi tessellation (Du et al., 1999). After the
random selection of 500 centroids, each region was constructed by
assigning the remaining voxels to one of the different centroids.
This regional allocation was performed by minimizing the
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thereby producing a 3-dimensional Voronoi tessellation. When ties
occurred, these were broken using random allocation. Conse-
quently, each region was composed of contiguous voxels with a
mean size of 364.7 voxels (sd 176.7).
Of the 500 regions, 29 were insufﬁciently covered by the fMRI
scans in some subjects, leaving 471 brain regions for further anal-
ysis. Individual subjects’ association matrices were constructed by
extracting a time series from each parcel and performing a wavelet
decomposition using a maximal overlap discrete wavelet transform
and a Daubechie wavelet ﬁlter using the brainwaver package in R
(http://cran.r-project.org/web/packages/brainwaver). The second
band of 4 corresponding to a frequency range of 0.0675e0.125 Hz
was selected for further analysis (Achard et al., 2006). Graphs were
constructed from association matrices without thresholding
(negativeweights retained) and based on the Fisher z-transforms of
the correlation coefﬁcients, and after wavelet decompositions of
the fMRI time series. Network analysis was carried out in python
2.7 using the Maybrain package in python (https://github.com/
rittman/maybrain) drawing on the networkx package (1.8.1,
http://networkx.github.io).
For comparisonwithmicroarray data, a mean associationmatrix
was constructed for each diagnostic group. This was generated by
calculating the mean connection strength of each brain region from
all subjects within a diagnostic group.
2.4. Hub deﬁnition and connectivity loss
Verbal ﬂuency scores were correlated with the mean connec-
tion strength of the most highly connected “hub” regions. In
the context of this paper, a hub was deﬁned as brain region
whose connection strength (the sum of all its connections) was
above a threshold of 1.5 standard deviations of the mean
connection strengths of all regions, based on the association
matrix in control subjects (see Supplementary Fig. 1 demon-
strating the location of hubs).
The proportion of connectivity loss between the control group
and PD or PSP group was calculated as the difference in connection
strength between groups for each brain region normalized by the
connectivity in the control group (Achard et al., 2012). Note that
proportionate, rather than absolute, loss of hub connectivity is
used, as hubs have by deﬁnition higher absolute connectivity,
whereas our hypotheses refer to the proportionate vulnerability of
hubs to the progression of neuropathology.
2.5. Microarray analysis
Microarray data available from the Allen brain atlas was gener-
ated using an Agilent 8  60 K array, custom-designed by Beckman
Coulter Genomics. From this data, we identiﬁed 4 probes for the
MAPT gene (A_23_P207699, A_24_P224488, A_32_P143793, and
CUST_449_PL1416408490) and 2 probes for the SNCA gene
(A_32_P109653 and A_23_29,939). The speciﬁcity of each probe
was reassessed using nucleotide BLAST (http://blast.ncbi.nlm.nih.
gov/Blast.cgi) to identify genes and translated nucleotide se-
quences associated with each probe’s sequence. Three of the 4
MAPT probes met our criteria: 100% homology with an area within
the MAPT gene and associated transcripts and no other regions of
homology, with very small E values to suggest good sensitivity.
These 3 probes matched regions in the MAPT gene, A_23_P207699
and A_24_P224488 homologous with the gene sequence to target
complementary DNA and A_32_P143793 with the anti-sense
sequence targeting complementary RNA. MAPT has 17 exons and
is alternately spliced into 6 isoforms, with 2 main groups differ-
entiated by 3 or 4 repeats of the binding domain as a result ofalternate splicing of exon 10. All probes recognized 3 and 4 repeat
tau. The fourth probe (CUST_449_PL1416408490) showed only 88%
homology with MAPT and 80% homology with a region on chro-
mosome 18 and was discarded. Two probes in the Allen brain atlas
data labeled as targeting SNCA (A_32_P109653 and A_23_29939)
had 100% homology with regions in the SNCA gene with small E
values. Both probes were homologous with complementary DNA.
Further detail on the microarray analysis methodology is available
from the Allen Institute (www.brain-map.org).
2.6. Comparison between microarray and functional network data
There were 3 challenges in identifying homologous regions
between the genetic and imaging data: (1) only 2 Allen subjects
have data from both hemispheres; (2) regions in the Allen data set
are not evenly spaced; and (3) the number and precise location of
regions differ between Allen subjects. To address the challenge of
missing data from the right hemisphere in 4 Allen subjects, the
remaining 2 subjects were used to correlate microarray expression
data between the hemispheres. We used the remaining 2 subjects
with whole brain data to assess whether it was reasonable to use
the single hemisphere data from the other 4 subjects to represent
whole brain. For each brain region, we calculated the Pearson cor-
relation coefﬁcient (Fisher’s r-to-z transformed to enable statistical
comparison) between the expression values of each hemisphere for
29,131 probes associated with an identiﬁed gene. Data for the null
hypothesis were generated by permuting interhemispheric brain
regions for 10,000 random region pairs. There was a signiﬁcant
difference between observed and permuted data for both subjects;
subject A mean z ¼ 0.46, p < 0.00001, subject B mean z ¼ 0.40, p <
0.00001. We therefore analyzed MAPT and SNCA data under the
assumption of symmetry of gene expression.
To address the second challenge of different spatial distributions
between imaging and genetic data, each imaging region was asso-
ciated with the nearest brain region from all Allen subjects com-
bined. Finally, each Allen brain region’s anatomical label was used
to identify comparable regions across the 6 Allen subjects, in
standard anatomical space. Each of the 471 imaging regions was
then paired with an anatomically labeled region of the Allen atlas
(see Supplementary Fig. 2 demonstrating regions of the Allen brain
atlas included in the ﬁnal analysis). For each region, the gene
expression valuewas calculated as themean of all samples falling in
to the appropriate brain regions from all 6 Allen subjects.
2.7. Statistical analysis
Statistical analysis was performed in R (Version 3.0.1 http://cran.
r-project.org). Groupwise differences in node degree were tested
using a t test with p-values obtained using permutation testing
(5000 permutations) and corrected for multiple comparisons using
the false discovery rate (Benjamini and Yekutieli, 2001). Correlation
between MAPT or SNCA expression and node degree used the
Pearson correlation coefﬁcient and p-values estimated from per-
mutation testing. To assess the relationship between verbal ﬂuency
and the proportional loss of connection strength in PD and PSP, a 1-
way analysis of variance was performed assessing themain effect of
connection strength on verbal ﬂuency.
3. Results
We measured functional connectivity among 471 of 500 gray
matter regions during task-free (or “resting-state”) fMRI in 128
subjects: 30 people with PD, 45 people with PSP, and 53 age- and
sex-matched healthy controls. Our principal measure of connec-
tivity was the sum of connection weights to all other regions
Fig. 1. The ﬁgure demonstrates the variability in microarray expression data between
the 6 Allen brain atlas subjects; the size of each sphere is scaled by the standard de-
viation of gene expression in the region. This was measured by normalizing the
expression values within each subject to a mean of 0 and standard deviation of 1, then
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matrix of z-transformed wavelet correlations. To assess the rela-
tionship between functional connection strength and gene
expression, we extracted the MAPT expression for each of 3 MAPT
probes and 2 SNCA probes in 6 subjects from the Allen Brain Atlas.
Fig. 1 illustrates the intersubject variation (i.e., standard deviation)
in gene expression for each probe. The expression values were
normalized for each probe within each subject: the mean
expression value for each probe was zero, and the standard
deviation was 1 for each probe (across all regions). Fig. 2A and B
illustrate the regional differences in the magnitude of MAPT and
SNCA gene expression.
There were positive correlations between MAPT expression and
the connection strength in control subjects when values from all 3
MAPT probes were combined (r ¼ 0.29, p  0.00001) and when
examined separately (Fig. 2C). The expression of SNCA did not
correlate with connection strength when combining data across
both probes (r ¼ 0.08, p > 0.1), although the expression values of 1
probe correlated weakly with connection strength (A 32 P109653,
r ¼ 0.12, p ¼ 0.036, see Fig. 2). Next, we related these effects to PD
and PSP.
We assessed whether regions of high connection strength were
susceptible to the effect of neurodegeneration in PD and PSP by
measuring the proportional loss of connection strength across
each of the 471 brain regions (Fig. 3). It is expected that regions
with more connections would lose more of these in absolute
terms, but the hypothesis of selective vulnerability posits that
well-connected regions lose a disproportionate number of con-
nections; therefore, our analysis examined the proportional loss of
connection strength. Brain regions with greater connection
strength in controls lost the largest proportion of connection
strength in PD (r ¼ 0.61, p < 0.00001 corrected) and PSP (r ¼ 0.44,
p < 0.00001). Brain regions that lost the greatest proportion of
connection strength also had greater expression ofMAPT in PD (r¼
0.16, p ¼ 0.0014, corrected for multiple comparisons across 2
genes using a Bonferroni correction) but not in PSP (r ¼ 0.06, p >
0.1), and there were no signiﬁcant associations with SNCA (PD: r ¼
0.02, p > 0.1, PSP: r ¼ 0.08, p > 0.1).
Finally, we examined the relevance of connectivity changes to
cognitive performance. Although PSP and PD have distinct clinical
phenotypes, both diseases are associated with early impairment of
executive function (Williams-Gray et al., 2007), which can be
indexed by verbal ﬂuency (Burrell et al., 2014). We identiﬁed the
most highly connected “hub” brain regions (as previously
mentioned) in control subjects and used the mean connection
strength across hubs, applying analysis of covariance to account
for the difference in distribution of verbal ﬂuency scores of each
group (Fig. 4). The mean verbal ﬂuency scores were controls 40.3
(standard deviation 10.4), PD 34.3 (7.3), and PSP 14.1 (8.6). The
connection strength of hub regions positively covaried with verbal
ﬂuency in both patient groups, that is, greater connection strength
was associated with greater verbal ﬂuency (F ¼ 6.1, df ¼ 1, p ¼
0.02). There was no interaction between this covariance and
diagnosis (F ¼ 1.3, df ¼ 1, p > 0.1), although post hoc correlations
demonstrated that verbal ﬂuency declined with the loss of hub
connectivity in PD (PD: r ¼ 0.52, df ¼ 21, p ¼ 0.01; PSP: r ¼ 0.21,
df ¼ 38, p > 0.1). Motor scores (Uniﬁed Parkinson’s Disease Rating
Scale) did not correlate with a loss of connection strength (F ¼
0.02, df ¼ 1, p > 0.1).=
assessing the interindividual standard deviation at each brain region. These results
conﬁrm an acceptable variability between subjects, with less variability in cortical
compared with subcortical regions. There were no regions with an unacceptably high
variability between subjects.
Fig. 2. The relationship between functional connection strength in control subjects and expression of MAPT and SNCA genes. The connection strength was measured in control
subjects as the mean r-to-z transformed wavelet cross-correlation between the task-free functional magnetic resonance imaging activity of a region and all other regions. Genetic
microarray expression data were obtained from the Allen brain database by matching regions in the Allen brain to brain regions imaged and aggregating expression values for gene
probes across subjects and normalized within each subject. (A) Shows the distribution of expression values for MAPT and SNCA aggregated across microarray probes using an
arbitrary scaling. In both genes, the cortex has greater gene expression than the cerebellum and subcortical regions. In MAPT, the posterior cortical regions including the precuneus
and posterior temporal lobe regions demonstrate greatest gene expression. (B) Shows glass brain projections of expression values for each probe individually. (C) Shows signiﬁcant
correlations between the regional distribution of functional connection strength and the expression of MAPT, a correlation that remained when values from the 3 probes were
aggregated (r ¼ 0.29, p < 0.00001 corrected). One of the SNCA probes weakly correlated with connection strength, although this did not survive when combining both SNCA probes
(r ¼ 0.08, p > 0.1 corrected).
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We have shown that the regional expression of theMAPTgene in
health is associatedwith regions of high connectivity, which predictFig. 3. The proportionate (not absolute) loss of connectivity strength in PSP and PD subjects
loss of connection strength in both PSP and PD, supporting the hypothesis that more co
(A) Shows the proportional loss of connection strength in disease by region. (B) Shows t
proportional change of connection strength in disease groups. Abbreviations: PD, Parkinsonthe functionally relevant loss of connectivity in PSP, a neurode-
generative diseases associated strongly with progressive misfolding
and aggregation of the protein tau. Similar changes were observed
in PD, which is more associated with alpha-synculein pathology butacross 471 regions. Functional connection strength in health predicts the proportional
nnected regions (including hubs) are particularly susceptible to neurodegeneration.
he signiﬁcant relationships between the connection strength in control subjects and
disease; PSP, progressive supranuclear palsy.
Fig. 4. The connection strength in highly connected hub brain regions correlates with
verbal ﬂuency in PD and PSP (F ¼ 6.1, df ¼ 1, p ¼ 0.02; post hoc t tests PD: r ¼ 0.52,
df ¼ 21, p ¼ 0.01; PSP: r ¼ 0.21, df ¼ 38, p > 0.1), but there was no correlation between
hub connection strength and motor function measured using UPDRS (F ¼ 0.02, df ¼ 1,
p > 0.1; post hoc t tests, PD: r ¼ 0.035, p ¼ 0.9; PSP r ¼ 0.038, p ¼ 0.8). Abbreviations:
PD, Parkinson disease; PSP, progressive supranuclear palsy; UPDRS, Uniﬁed Parkinson’s
Disease Rating Scale.
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associated with tau haplotypes.
Accumulating evidence points to the susceptibility of highly
connected hub regions to change in a wide range of neurological
and neuropsychiatric disease (Crossley et al., 2014). This evidence
includes neurodegenerative syndromes such as Alzheimer’s dis-
ease, where the hub selectivity of connection strength has been
linked to greater metabolic demands (Buckner et al., 2009). Highly
connected brain regions can also be considered “expensive” to
maintain because they have large numbers of connections, which
may make them vulnerable to disease processes because of their
high metabolism (Achard and Bullmore, 2007), or through “hub
overload” of information that would usually be managed by otherdisease-affected brain regions (Stam, 2014). Furthermore, greater
connectivity may increase the probability of transferring and
receiving harmful protein species (Clavaguera et al., 2013; Liu
et al., 2012).
Our ﬁndings extend these network-based hypotheses by link-
ing global network properties directly to the underlying expres-
sion of native tau in humans. Global network properties have been
found to mirror patterns in gene expression (Fulcher and Fornito,
2016; Rubinov et al., 2015; Vértes et al., 2016), and more specif-
ically, the association between MAPT expression and connection
strength reﬂects the importance of the tau protein in maintaining
axonal integrity by stabilizing microtubules (Lindwall and Cole,
1984). In humans, previous imaging studies have linked single
gene variants with patterns of change in brain imaging (Filippini
et al., 2009; Mata et al., 2014; Whitwell et al., 2011). We go
further to suggest that the regional variation in the MAPT gene
expression in health can contribute to the selective vulnerability
of a densely connected region speciﬁcally, more highly connected
regions may be intrinsically susceptible to neurodegeneration
mediated by tau dysfunction.
The correlation between MAPT expression and the proportional
loss of connection strength was greater in PD than for PSP. The
variability between these 2 diseases suggests that multiple genes
and disease processes are involved in the loss of functional con-
nections between brain regions. Our approach was to test an hy-
pothesis based on a known gene associated with cognitive changes
in the 2 disorders of interest. A more exploratory approach inves-
tigating all the available microarray data in the Allen brain atlas is
technically possible (Hibar, 2015) and may identify other contrib-
uting genes but would require careful control of type I statistical
error. Our study was not powered to conduct such a study.
In contrast toMAPT, we did not ﬁnd a strong association between
SNCA expression and functional connectivity in health, or loss of
connectivity in disease. There was a weak association between 1
SNCA probe and connectivity in health, but this was not matched by
changes in disease. This is despite the association of PD with alpha-
synuclein pathology. Lewy bodies containing alpha-synuclein are the
hallmark of PD pathology (Spillantini et al., 1997), and there is now
emerging evidence that alpha-synuclein could spread across neural
networks and cause aggregation and cell loss through a prion-like
process (Hansen and Li, 2012; Li et al., 2008). There is a correlation
between cortical deposition of alpha-synuclein and dementia
(Hurtig et al., 2000); however, our cohort of PD patients speciﬁcally
excluded patients with dementia. We suggest that the role of alpha-
synuclein in PD without dementia is not relevant to the more
cortically derived network measures that we employed to examine
large scale network functional connectivity.
We have examined functional connection strength across the
whole brain, but the brain’s functional network can be examined as
a series of macroscopic brain networks, some of which have been
associated with individual neurodegenerative diseases (Seeley
et al., 2009). In the context of our results, the recent ﬁnding that
gene expression may predict connectivity patterns (Hawrylycz
et al., 2015; Richiardi et al., 2015) raises the possibility that gene
expression patterns and their products may contribute to the sus-
ceptibility of speciﬁc brain networks to speciﬁc neurodegenerative
pathologies.
We identiﬁed a clinical effect of destabilizing highly connected
hub regions by demonstrating that verbal ﬂuency declines with a
loss of connection strength. Verbal ﬂuency is a key component of
early cognitive impairment in both PD and PSP (Rittman et al., 2013)
and arises from the orchestrated function of multiple brain regions
(Henry and Crawford, 2004). Therefore, a loss of the coordinating
function of highly connected brain regions is expected to have a
detrimental effect on verbal ﬂuency.
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genes relevant to PSP and PD. This contrasts with an exploratory
data-driven approach (Hawrylycz et al., 2015; Richiardi et al., 2015),
which may reduce the statistical power to detect relevant effects of
individual genes. However, we recognize that there are likely to be
other genes that play a role in the pathology underlying PD and PSP
whose differential expression may contribute to pathogenesis.
There are a number of limitations to this study. First, the gene
expression data and imaging data were necessarily obtained from
different populations. Although our hypothesis was based on evi-
dence for the involvement of tau in both PD and PSP, we recognize
that gene-connectivity relationships may not exist in all disorders
where there is a change in connectivity; and therefore, a more
direct imaging-pathologic correlation in a single population would
be the optimum approach. Second, the Allen database from which
the gene expression data was derived includes only 6 subjects
raising the possibility that interindividual variance may account for
our ﬁndings. However, the main statistical comparison was among
the 471 deﬁned brain regions rather than the 6 individuals, and in 5
of the 6 subjects, we found similarly signiﬁcant within-subject
correlations between MAPT expression and connection strength
demonstrating that our results were not dependent on 1 or 2
subjects. Finally, our results may not be speciﬁc for PD and PSP. It
will be important to replicate our ﬁndings in independent cohorts
and in other tau-associated neurodegenerative disorders such as
Alzheimer’s disease and frontotemporal dementia.
In conclusion, our results link molecular and imaging data in
support of hypotheses of network vulnerability to neurodegener-
ative pathologies. We propose that brain regions expressing greater
levels of theMAPT gene are more susceptible to neurodegeneration
associated with the MAPT haplotype or mediated by tau pathology.
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